WATER

WATER was reported 12918 times

WATER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYSOSOMAL STORAGE DISORDER 6 0.3158
1 PANTOEA AGGLOMERANS INFECTION 6 0.0779
2 HEREDITARY ANGIOEDEMA 584 0.0544
3 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 7 0.0543
4 DEAFNESS PERMANENT 9 0.0459
5 GLYCOGEN STORAGE DISEASE TYPE II 4 0.0381
6 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 3 0.0375
7 AIDS ENCEPHALOPATHY 2 0.0345
8 USE OF ACCESSORY RESPIRATORY MUSCLES 14 0.0339
9 HYDROSALPINX 3 0.0326
10 CENTRAL VENOUS CATHETER REMOVAL 10 0.0213
11 ENDOCRINE OPHTHALMOPATHY 17 0.0196
12 BILIRUBIN URINE PRESENT 2 0.0168
13 CATHETER REMOVAL 6 0.0168
14 IN VITRO FERTILISATION 3 0.0166
15 ENTEROBACTER TEST POSITIVE 4 0.0163
16 CATHETER SITE VESICLES 3 0.0154
17 VASCULAR DEVICE OCCLUSION 5 0.0147
18 CATHETER SITE THROMBOSIS 4 0.0146
19 LIP INFECTION 3 0.0142
20 PRODUCT COMPOUNDING QUALITY ISSUE 5 0.0137
21 PERIARTHRITIS 30 0.0132
22 VASCULAR ACCESS COMPLICATION 10 0.0123
23 PRODUCT RECONSTITUTION QUALITY ISSUE 11 0.0123
24 CATHETER SITE IRRITATION 4 0.0120
25 ALLERGY TO PLANTS 5 0.0109
26 GRANULOCYTE COUNT DECREASED 20 0.0108
27 CATHETER SITE SWELLING 10 0.0107
28 MITOCHONDRIAL TOXICITY 8 0.0097
29 DEVICE RELATED BACTERAEMIA 3 0.0097
30 KLEBSIELLA TEST POSITIVE 6 0.0092
31 NEONATAL INFECTION 3 0.0087
32 OVARIAN HYPERSTIMULATION SYNDROME 20 0.0086
33 POOR VENOUS ACCESS 88 0.0085
34 FACIAL DISCOMFORT 6 0.0085
35 CATHETER SITE EXTRAVASATION 3 0.0075
36 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
37 ANHIDROSIS 3 0.0074
38 VASCULAR DEVICE INFECTION 33 0.0073
39 NAIL OPERATION 3 0.0072
40 PRODUCT CLOSURE ISSUE 4 0.0072
41 CATHETER SITE PRURITUS 6 0.0068
42 CENTRAL VENOUS CATHETERISATION 20 0.0066
43 CATHETER SITE PAIN 17 0.0065
44 VEIN RUPTURE 10 0.0060
45 URINARY TRACT PAIN 3 0.0059
46 SUPERFICIAL VEIN THROMBOSIS 5 0.0059
47 LARYNGEAL DISORDER 4 0.0055
48 CERUMEN IMPACTION 5 0.0055
49 CATHETER PLACEMENT 10 0.0054
50 ADMINISTRATION SITE PAIN 6 0.0052
51 ASYMPTOMATIC COVID-19 2 0.0051
52 MEDICAL DEVICE SITE INFECTION 3 0.0048
53 SPINAL CORD INFECTION 3 0.0046
54 INSURANCE ISSUE 70 0.0046
55 DEAFNESS NEUROSENSORY 15 0.0046
56 LARYNGEAL OEDEMA 28 0.0045
57 DEVICE RELATED SEPSIS 9 0.0045
58 BLOOD MAGNESIUM INCREASED 4 0.0044
59 PRODUCT PREPARATION ISSUE 29 0.0044
60 ALLERGY TO ARTHROPOD STING 2 0.0044
61 MAST CELL ACTIVATION SYNDROME 6 0.0043
62 SUTURE RELATED COMPLICATION 3 0.0042
63 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
64 HAEMATOLOGICAL INFECTION 10 0.0041
65 ALLERGY TO CHEMICALS 5 0.0040
66 INFUSION SITE SWELLING 25 0.0040
67 MYELOSUPPRESSION 143 0.0040
68 CATHETER SITE INFECTION 15 0.0040
69 TRACHEITIS 3 0.0039
70 INFUSION SITE DISCOMFORT 4 0.0039
71 INFUSION SITE EXTRAVASATION 24 0.0039
72 CROUP INFECTIOUS 3 0.0038
73 POOR QUALITY PRODUCT ADMINISTERED 40 0.0038
74 PRESCRIBED OVERDOSE 73 0.0038
75 LIPODYSTROPHY ACQUIRED 8 0.0038
76 MAMMOPLASTY 3 0.0038
77 CATHETER SITE ERYTHEMA 8 0.0037
78 IDIOPATHIC URTICARIA 4 0.0037
79 PRODUCT SELECTION ERROR 4 0.0036
80 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
81 DEVICE RELATED INFECTION 54 0.0035
82 INFUSION SITE INFECTION 8 0.0034
83 INCORRECT PRODUCT FORMULATION ADMINISTERED 3 0.0034
84 PRODUCT LEAKAGE 19 0.0034
85 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
86 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
87 EXOPHTHALMOS 7 0.0033
88 PRODUCT APPEARANCE CONFUSION 3 0.0032
89 VENOUS INJURY 3 0.0032
90 PSYCHOGENIC SEIZURE 3 0.0032
91 OVARIAN CYST RUPTURED 4 0.0031
92 SPINAL LAMINECTOMY 3 0.0031
93 DEVICE RELATED THROMBOSIS 3 0.0030
94 INFUSION SITE HAEMORRHAGE 10 0.0030
95 INFUSION SITE PAIN 39 0.0030
96 SIALOADENITIS 4 0.0029
97 INFUSION SITE RASH 4 0.0029
98 TREATMENT DELAYED 5 0.0029
99 CYSTIC FIBROSIS 16 0.0029
100 PRODUCT PACKAGING CONFUSION 7 0.0029
101 PHARYNGITIS STREPTOCOCCAL 31 0.0029
102 INFUSION SITE DISCHARGE 5 0.0028
103 NOROVIRUS INFECTION 4 0.0028
104 POST PROCEDURAL SWELLING 3 0.0027
105 DERMATITIS CONTACT 31 0.0027
106 BLOODY DISCHARGE 3 0.0026
107 INFUSION SITE ERYTHEMA 22 0.0026
108 PRURITUS ALLERGIC 3 0.0026
109 PRODUCT DEPOSIT 4 0.0026
110 JAUNDICE CHOLESTATIC 9 0.0025
111 OPHTHALMOPLEGIA 4 0.0025
112 PRODUCT CONTAMINATION 9 0.0025
113 DIABETES INSIPIDUS 6 0.0025
114 RENAL TRANSPLANT 9 0.0025
115 INFUSION SITE WARMTH 3 0.0024
116 HYPOMANIA 9 0.0024
117 DEVICE INFUSION ISSUE 6 0.0024
118 PRODUCT CONTAMINATION PHYSICAL 6 0.0024
119 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
120 INFUSION SITE IRRITATION 3 0.0023
121 WEIGHT FLUCTUATION 24 0.0023
122 WISDOM TEETH REMOVAL 3 0.0023
123 CORNEAL ABRASION 3 0.0022
124 SINUS PAIN 5 0.0021
125 APPENDIX DISORDER 3 0.0021
126 SKIN ABRASION 10 0.0021
127 OXYGEN SATURATION ABNORMAL 6 0.0021
128 WEIGHT ABNORMAL 5 0.0021
129 PRODUCT DISTRIBUTION ISSUE 19 0.0020
130 MULTIPLE ALLERGIES 16 0.0020
131 INFUSION SITE REACTION 6 0.0020
132 HYPERNATRAEMIA 10 0.0020
133 GASTROENTERITIS VIRAL 36 0.0020
134 SEASONAL ALLERGY 28 0.0020
135 BRAIN DEATH 6 0.0019
136 INFERTILITY FEMALE 3 0.0019
137 BLOOD PHOSPHORUS DECREASED 7 0.0019
138 INFUSION SITE PRURITUS 6 0.0019
139 EYE CONTUSION 4 0.0019
140 PHARYNGEAL PARAESTHESIA 3 0.0019
141 ANIMAL BITE 5 0.0019
142 INFUSION SITE BRUISING 4 0.0019
143 COSTOCHONDRITIS 3 0.0018
144 COLONOSCOPY 4 0.0018
145 ARTHROPOD STING 3 0.0018
146 PRODUCT PREPARATION ERROR 37 0.0018
147 FAECES HARD 7 0.0018
148 VEIN DISORDER 9 0.0018
149 GASTROINTESTINAL INFECTION 16 0.0018
150 EXPOSURE TO SARS-COV-2 3 0.0018
151 CARBOHYDRATE ANTIGEN 125 INCREASED 6 0.0018
152 PUPIL FIXED 3 0.0017
153 HAEMOLYTIC URAEMIC SYNDROME 4 0.0017
154 EAR INFECTION 45 0.0017
155 JUGULAR VEIN THROMBOSIS 3 0.0017
156 TETANY 3 0.0016
157 BODY TEMPERATURE ABNORMAL 3 0.0016
158 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
159 DENTAL CARE 3 0.0016
160 HYPERVOLAEMIA 8 0.0016
161 CATHETER SITE HAEMORRHAGE 4 0.0016
162 PARANASAL SINUS DISCOMFORT 6 0.0016
163 PHYSICAL DISABILITY 7 0.0016
164 GINGIVAL RECESSION 3 0.0016
165 PHARYNGEAL OEDEMA 24 0.0016
166 RESPIRATORY TRACT INFECTION 40 0.0015
167 NASAL SEPTUM DEVIATION 3 0.0015
168 BACTERAEMIA 18 0.0015
169 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
170 SARS-COV-2 TEST POSITIVE 20 0.0015
171 EXPOSURE VIA BREAST MILK 6 0.0015
172 WRONG PRODUCT ADMINISTERED 10 0.0015
173 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
174 EAR DISCOMFORT 15 0.0015
175 CHEST INJURY 3 0.0014
176 STREPTOCOCCAL INFECTION 8 0.0014
177 INTRACRANIAL PRESSURE INCREASED 8 0.0014
178 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
179 SINUSITIS 145 0.0014
180 LUNG TRANSPLANT 5 0.0014
181 AUDITORY DISORDER 2 0.0014
182 POOR QUALITY DRUG ADMINISTERED 9 0.0014
183 EYELID MARGIN CRUSTING 4 0.0014
184 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
185 RALES 8 0.0014
186 ACUTE ABDOMEN 2 0.0014
187 WRONG DRUG ADMINISTERED 12 0.0013
188 TONGUE BLISTERING 3 0.0013
189 LARGE INTESTINAL OBSTRUCTION 3 0.0013
190 INFECTIOUS MONONUCLEOSIS 3 0.0013
191 PRODUCT LABEL ISSUE 9 0.0013
192 RESPIRATORY TRACT CONGESTION 21 0.0013
193 EMERGENCY CARE 4 0.0013
194 LIGAMENT SPRAIN 13 0.0013
195 RHINOVIRUS INFECTION 5 0.0013
196 ORAL SURGERY 3 0.0013
197 BACTERIAL VAGINOSIS 2 0.0013
198 DYSPNOEA EXERTIONAL 48 0.0013
199 MUSCLE STRAIN 11 0.0013
200 HAND FRACTURE 9 0.0013
201 INGROWING NAIL 3 0.0013
202 SINUS CONGESTION 17 0.0013
203 TENDERNESS 13 0.0012
204 EYE INFECTION 14 0.0012
205 DRUG EFFECT INCOMPLETE 45 0.0012
206 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
207 DERMAL CYST 3 0.0012
208 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 219 0.0012
209 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
210 SKIN WARM 7 0.0012
211 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
212 BRAIN OEDEMA 15 0.0012
213 PRODUCT AVAILABILITY ISSUE 27 0.0012
214 CANDIDA INFECTION 20 0.0012
215 NEUTROPHIL COUNT DECREASED 48 0.0012
216 PRODUCT COLOUR ISSUE 6 0.0012
217 PRODUCT CONTAINER ISSUE 10 0.0012
218 HERNIA REPAIR 3 0.0012
219 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
220 URINE OUTPUT INCREASED 3 0.0011
221 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
222 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
223 POST PROCEDURAL INFECTION 9 0.0011
224 WEIGHT INCREASED 246 0.0011
225 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
226 HAEMOGLOBIN INCREASED 5 0.0011
227 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37 0.0011
228 RED BLOOD CELL COUNT INCREASED 3 0.0011
229 PLEURITIC PAIN 3 0.0011
230 LOCALISED OEDEMA 5 0.0011
231 ARTHRITIS INFECTIVE 5 0.0011
232 HEART RATE ABNORMAL 6 0.0011
233 ENDOTRACHEAL INTUBATION 3 0.0011
234 SKIN INFECTION 12 0.0011
235 RESPIRATORY SYMPTOM 3 0.0011
236 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
237 LIP PAIN 3 0.0010
238 CLAVICLE FRACTURE 4 0.0010
239 FOOD ALLERGY 8 0.0010
240 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
241 DYSPNOEA AT REST 3 0.0010
242 DEVICE POWER SOURCE ISSUE 3 0.0010
243 INFUSION RELATED REACTION 68 0.0010
244 ILLNESS 105 0.0010
245 ONYCHOCLASIS 7 0.0010
246 PRODUCT USE COMPLAINT 16 0.0010
247 BREATH SOUNDS ABNORMAL 5 0.0010
248 MUCOUS STOOLS 5 0.0010
249 BRAIN HERNIATION 3 0.0010
250 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
251 BLOOD CULTURE POSITIVE 3 0.0010
252 OBSTRUCTION 4 0.0010
253 TENSION 6 0.0010
254 EYELID PTOSIS 10 0.0010
255 PERIPHERAL VENOUS DISEASE 4 0.0010
256 EAR PAIN 19 0.0010
257 ENDOCARDITIS 5 0.0010
258 IMPAIRED QUALITY OF LIFE 14 0.0010
259 DIASTOLIC DYSFUNCTION 3 0.0010
260 BACTERIAL INFECTION 18 0.0010
261 TONSILLITIS 5 0.0010
262 BREAST CANCER RECURRENT 3 0.0009
263 NEURALGIA 23 0.0009
264 ARTHROPOD BITE 7 0.0009
265 SHOULDER OPERATION 4 0.0009
266 HYSTERECTOMY 8 0.0009
267 WRIST FRACTURE 11 0.0009
268 KIDNEY INFECTION 18 0.0009
269 DRUG DISPENSING ERROR 14 0.0009
270 PRODUCT DOSE OMISSION ISSUE 269 0.0009
271 PULMONARY FUNCTION TEST DECREASED 4 0.0009
272 INJECTION SITE INFECTION 3 0.0009
273 CYSTITIS 29 0.0009
274 ACCIDENT AT WORK 2 0.0009
275 VIRAL INFECTION 30 0.0009
276 BACTERIAL TEST POSITIVE 2 0.0009
277 PERIORBITAL SWELLING 5 0.0009
278 LIMB INJURY 24 0.0009
279 FURUNCLE 7 0.0009
280 DRUG EFFECT DELAYED 4 0.0009
281 BODY TEMPERATURE INCREASED 18 0.0009
282 STAPHYLOCOCCAL INFECTION 29 0.0009
283 COVID-19 152 0.0009
284 SYNOVIAL CYST 4 0.0009
285 WEIGHT DECREASED 241 0.0009
286 ELECTROLYTE IMBALANCE 10 0.0009
287 DEFAECATION URGENCY 6 0.0009
288 TIBIA FRACTURE 4 0.0009
289 DEVICE OCCLUSION 12 0.0009
290 DIPLOPIA 22 0.0008
291 NASOPHARYNGITIS 156 0.0008
292 FIBRIN D DIMER INCREASED 3 0.0008
293 PROTHROMBIN TIME PROLONGED 5 0.0008
294 LIMB OPERATION 4 0.0008
295 DIZZINESS POSTURAL 8 0.0008
296 INFLUENZA 92 0.0008
297 SCHIZOPHRENIA 10 0.0008
298 PNEUMOTHORAX 13 0.0008
299 SCAR 14 0.0008
300 NO ADVERSE EVENT 148 0.0008
301 THERAPY CHANGE 8 0.0008
302 SPINAL OPERATION 10 0.0008
303 BLOOD MAGNESIUM DECREASED 7 0.0008
304 SINUS DISORDER 16 0.0008
305 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
306 PRODUCTIVE COUGH 38 0.0008
307 APPENDICITIS PERFORATED 2 0.0008
308 PARANASAL SINUS HYPERSECRETION 3 0.0008
309 INJECTION SITE IRRITATION 10 0.0008
310 CHILLS 92 0.0008
311 GASTRIC INFECTION 3 0.0008
312 OESOPHAGEAL DISORDER 3 0.0008
313 PRODUCT DOSE OMISSION IN ERROR 22 0.0008
314 CONCUSSION 6 0.0008
315 OROPHARYNGEAL DISCOMFORT 7 0.0008
316 CHEST DISCOMFORT 79 0.0008
317 PERIORBITAL OEDEMA 4 0.0008
318 SCRATCH 8 0.0008
319 JOINT INJURY 16 0.0007
320 ABDOMINAL MASS 2 0.0007
321 FUNGAL SKIN INFECTION 3 0.0007
322 MYASTHENIA GRAVIS 6 0.0007
323 PAIN IN JAW 21 0.0007
324 FOOT FRACTURE 14 0.0007
325 INTENTIONAL DOSE OMISSION 21 0.0007
326 SKIN LACERATION 8 0.0007
327 ANAPHYLACTOID REACTION 3 0.0007
328 WHITE BLOOD CELL COUNT DECREASED 79 0.0007
329 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
330 FUNGAL INFECTION 24 0.0007
331 HEPATOTOXICITY 16 0.0007
332 MASS 10 0.0007
333 NASAL CONGESTION 42 0.0007
334 BURNING SENSATION 50 0.0007
335 HYPERPYREXIA 3 0.0007
336 THERMAL BURN 5 0.0007
337 GRANULOCYTOPENIA 4 0.0007
338 BRAIN FOG 11 0.0007
339 PRODUCT SUPPLY ISSUE 5 0.0007
340 HORDEOLUM 3 0.0007
341 PRODUCT PRESCRIBING ISSUE 15 0.0007
342 IMMOBILE 3 0.0007
343 PRODUCT LABEL CONFUSION 4 0.0007
344 ABDOMINAL DISTENSION 71 0.0007
345 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
346 CATHETERISATION CARDIAC 3 0.0007
347 SINUS HEADACHE 4 0.0007
348 ATYPICAL PNEUMONIA 2 0.0007
349 ANAL INCONTINENCE 6 0.0007
350 THROAT TIGHTNESS 18 0.0007
351 BLOOD POTASSIUM DECREASED 20 0.0007
352 ACNE CYSTIC 2 0.0007
353 OSTEOMYELITIS 12 0.0007
354 THROMBOSIS 53 0.0007
355 ABDOMINAL HERNIA 3 0.0007
356 WHEEZING 39 0.0007
357 BLOOD UREA INCREASED 11 0.0007
358 HEART RATE INCREASED 65 0.0007
359 LUMBAR VERTEBRAL FRACTURE 3 0.0007
360 ANAPHYLACTIC REACTION 36 0.0007
361 PHARYNGITIS 8 0.0006
362 HOSPITALISATION 99 0.0006
363 PULMONARY THROMBOSIS 7 0.0006
364 GASTROINTESTINAL PAIN 7 0.0006
365 DIALYSIS 9 0.0006
366 PRODUCT PACKAGING ISSUE 6 0.0006
367 PYREXIA 217 0.0006
368 MYDRIASIS 8 0.0006
369 PROCTALGIA 4 0.0006
370 BRONCHITIS 46 0.0006
371 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
372 HORMONE LEVEL ABNORMAL 3 0.0006
373 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
374 FEELING COLD 17 0.0006
375 CHOLELITHIASIS 20 0.0006
376 ESCHERICHIA INFECTION 5 0.0006
377 CORONAVIRUS INFECTION 4 0.0006
378 BLOOD PRESSURE ABNORMAL 12 0.0006
379 ANEURYSM 3 0.0006
380 PROTEIN URINE PRESENT 3 0.0006
381 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
382 PRODUCT USE ISSUE 113 0.0006
383 PREGNANCY 12 0.0006
384 SWELLING 56 0.0006
385 INFECTION 86 0.0006
386 POSTOPERATIVE WOUND INFECTION 4 0.0006
387 DISCOMFORT 36 0.0006
388 TOOTH ABSCESS 6 0.0006
389 TACHYPNOEA 8 0.0006
390 COUGH 165 0.0006
391 TINNITUS 27 0.0006
392 EYE MOVEMENT DISORDER 4 0.0006
393 CONTUSION 56 0.0006
394 TEMPERATURE INTOLERANCE 6 0.0006
395 VARICOSE VEIN 3 0.0006
396 GASTROINTESTINAL DISORDER 52 0.0006
397 EXPOSURE DURING PREGNANCY 36 0.0006
398 LOCALISED INFECTION 14 0.0006
399 EYE DISCHARGE 6 0.0006
400 MIGRAINE 55 0.0006
401 ROAD TRAFFIC ACCIDENT 24 0.0006
402 PARTIAL SEIZURES 3 0.0006
403 POST PROCEDURAL COMPLICATION 11 0.0006
404 URINE OUTPUT DECREASED 5 0.0006
405 NAIL DISORDER 5 0.0006
406 PAPULE 4 0.0006
407 HYPERCALCAEMIA 7 0.0006
408 PRODUCT COMMUNICATION ISSUE 5 0.0006
409 RENAL PAIN 6 0.0006
410 RETCHING 12 0.0006
411 TOOTH EXTRACTION 7 0.0006
412 APPENDICECTOMY 2 0.0006
413 FOOD POISONING 3 0.0006
414 BLOOD BILIRUBIN INCREASED 15 0.0006
415 HIP SURGERY 3 0.0006
416 PALLOR 15 0.0006
417 WOUND INFECTION 6 0.0005
418 SWOLLEN TONGUE 17 0.0005
419 TOOTH FRACTURE 6 0.0005
420 SENSITIVE SKIN 4 0.0005
421 AGRANULOCYTOSIS 10 0.0005
422 ANGIOPATHY 3 0.0005
423 APPENDICITIS 5 0.0005
424 ORAL CANDIDIASIS 7 0.0005
425 OROPHARYNGEAL PAIN 49 0.0005
426 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
427 URINARY TRACT INFECTION 89 0.0005
428 PROCEDURAL COMPLICATION 4 0.0005
429 EXERCISE TOLERANCE DECREASED 3 0.0005
430 OEDEMA 28 0.0005
431 MATERNAL EXPOSURE DURING PREGNANCY 46 0.0005
432 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
433 PHARYNGEAL SWELLING 5 0.0005
434 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
435 HEAD DISCOMFORT 9 0.0005
436 BLOOD IRON DECREASED 6 0.0005
437 HEAD INJURY 16 0.0005
438 CARDIAC PACEMAKER INSERTION 3 0.0005
439 NEPHROLITHIASIS 23 0.0005
440 RESPIRATORY DISORDER 15 0.0005
441 SYMPTOM RECURRENCE 3 0.0005
442 BLOOD PRESSURE DECREASED 33 0.0005
443 LACRIMATION INCREASED 15 0.0005
444 RHINITIS 4 0.0005
445 SLUGGISHNESS 5 0.0005
446 CYTOPENIA 6 0.0005
447 DRUG LEVEL INCREASED 8 0.0005
448 RASH ERYTHEMATOUS 23 0.0005
449 RHINORRHOEA 31 0.0005
450 SWELLING OF EYELID 3 0.0005
451 TRANSFUSION 5 0.0005
452 BLEPHAROSPASM 3 0.0005
453 PSYCHOTIC DISORDER 14 0.0005
454 PNEUMONIA 153 0.0005
455 FOREIGN BODY SENSATION IN EYES 3 0.0005
456 DIVERTICULITIS 13 0.0005
457 SEPSIS 52 0.0005
458 UNRESPONSIVE TO STIMULI 12 0.0005
459 SKIN SWELLING 4 0.0005
460 BLOOD PRESSURE INCREASED 70 0.0005
461 FALL 152 0.0005
462 ASPIRATION 5 0.0005
463 GROIN PAIN 4 0.0005
464 TOOTH INFECTION 6 0.0005
465 PULMONARY CONGESTION 6 0.0005
466 WALKING AID USER 3 0.0005
467 PRODUCT FORMULATION ISSUE 3 0.0005
468 COLD SWEAT 8 0.0005
469 VOMITING 213 0.0005
470 ABDOMINAL ABSCESS 2 0.0005
471 ADVERSE REACTION 6 0.0005
472 UPPER LIMB FRACTURE 9 0.0005
473 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
474 FULL BLOOD COUNT DECREASED 9 0.0004
475 DEVICE ISSUE 40 0.0004
476 SNEEZING 10 0.0004
477 THROAT IRRITATION 20 0.0004
478 HYPOACUSIS 19 0.0004
479 ABNORMAL LOSS OF WEIGHT 3 0.0004
480 ULCER 7 0.0004
481 BLOOD TESTOSTERONE DECREASED 3 0.0004
482 INTERNAL HAEMORRHAGE 5 0.0004
483 MENTAL DISORDER 19 0.0004
484 INCREASED TENDENCY TO BRUISE 4 0.0004
485 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
486 HAEMATEMESIS 11 0.0004
487 CONJUNCTIVITIS 8 0.0004
488 HAEMOPTYSIS 12 0.0004
489 EXTRASYSTOLES 3 0.0004
490 SPLENOMEGALY 5 0.0004
491 HEADACHE 266 0.0004
492 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
493 CELLULITIS 21 0.0004
494 EYE PRURITUS 14 0.0004
495 ACUTE RESPIRATORY FAILURE 8 0.0004
496 AFFECT LABILITY 4 0.0004
497 VISUAL FIELD DEFECT 3 0.0004
498 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
499 MEDICATION ERROR 23 0.0004
500 HERNIA 8 0.0004
501 ERUCTATION 8 0.0004
502 FAECES SOFT 3 0.0004
503 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
504 HEPATIC ENZYME INCREASED 28 0.0004
505 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
506 OXYGEN SATURATION DECREASED 23 0.0004
507 ABDOMINAL PAIN 95 0.0004
508 HYPONATRAEMIA 23 0.0004
509 FEELING HOT 25 0.0004
510 PRODUCT USE IN UNAPPROVED INDICATION 101 0.0004
511 HEPATOMEGALY 4 0.0004
512 VITREOUS FLOATERS 4 0.0004
513 BODY TEMPERATURE DECREASED 4 0.0004
514 CHEST PAIN 75 0.0004
515 HAEMATOCRIT DECREASED 8 0.0004
516 BLADDER DISORDER 4 0.0004
517 INABILITY TO AFFORD MEDICATION 4 0.0004
518 HEPATIC FUNCTION ABNORMAL 15 0.0004
519 HYDRONEPHROSIS 3 0.0004
520 HYPOTONIA 4 0.0004
521 SALIVARY HYPERSECRETION 4 0.0004
522 SECRETION DISCHARGE 5 0.0004
523 DYSARTHRIA 15 0.0004
524 HYPOXIA 14 0.0004
525 DERMATITIS ALLERGIC 5 0.0004
526 PALPITATIONS 46 0.0004
527 MUSCLE SPASMS 72 0.0004
528 BOWEL MOVEMENT IRREGULARITY 3 0.0004
529 EXPIRED PRODUCT ADMINISTERED 13 0.0004
530 NEUTROPHIL COUNT INCREASED 4 0.0004
531 PERICARDIAL EFFUSION 9 0.0004
532 ANAPHYLACTIC SHOCK 10 0.0004
533 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
534 APNOEA 3 0.0004
535 CONDITION AGGRAVATED 117 0.0004
536 PAIN 236 0.0004
537 DYSPNOEA 217 0.0004
538 PETECHIAE 4 0.0004
539 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
540 PRODUCT ODOUR ABNORMAL 4 0.0004
541 AFFECTIVE DISORDER 3 0.0004
542 JOINT SWELLING 46 0.0004
543 KNEE ARTHROPLASTY 8 0.0004
544 HAEMATURIA 13 0.0004
545 OCULAR HYPERAEMIA 18 0.0004
546 PERIPHERAL SWELLING 58 0.0004
547 SCIATICA 6 0.0004
548 FATIGUE 293 0.0004
549 PLATELET COUNT DECREASED 40 0.0004
550 EYE HAEMORRHAGE 5 0.0004
551 FLUSHING 38 0.0004
552 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
553 HEPATIC CIRRHOSIS 7 0.0004
554 EYE PAIN 21 0.0004
555 HYPERSENSITIVITY 69 0.0004
556 BLOOD SODIUM DECREASED 7 0.0004
557 FRUSTRATION TOLERANCE DECREASED 3 0.0004
558 MUSCLE TIGHTNESS 6 0.0004
559 BLOOD POTASSIUM INCREASED 6 0.0004
560 DECUBITUS ULCER 3 0.0004
561 BACK INJURY 4 0.0004
562 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
563 GINGIVAL BLEEDING 5 0.0004
564 ABNORMAL FAECES 3 0.0004
565 HERPES ZOSTER 21 0.0004
566 PERIPHERAL COLDNESS 5 0.0004
567 URTICARIA 61 0.0004
568 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
569 VERTIGO 22 0.0004
570 EPISTAXIS 27 0.0004
571 PNEUMONIA ASPIRATION 9 0.0004
572 SURGERY 21 0.0004
573 PERICARDITIS 6 0.0004
574 OCULAR DISCOMFORT 4 0.0004
575 SENSATION OF FOREIGN BODY 3 0.0004
576 FISTULA 4 0.0004
577 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
578 LIMB DISCOMFORT 11 0.0004
579 HYPERTENSION 75 0.0004
580 HEART RATE IRREGULAR 8 0.0004
581 DYSURIA 13 0.0004
582 PAIN IN EXTREMITY 104 0.0004
583 DRUG-INDUCED LIVER INJURY 11 0.0004
584 MICTURITION URGENCY 4 0.0003
585 CHOLECYSTECTOMY 4 0.0003
586 NAUSEA 277 0.0003
587 PSEUDOMONAS INFECTION 3 0.0003
588 HYPERSOMNIA 10 0.0003
589 NEOPLASM 4 0.0003
590 EYE IRRITATION 20 0.0003
591 PRODUCT PHYSICAL ISSUE 7 0.0003
592 PRODUCT ADMINISTRATION ERROR 7 0.0003
593 SEIZURE 40 0.0003
594 HAEMATOCHEZIA 19 0.0003
595 BLOOD CALCIUM INCREASED 3 0.0003
596 ERYTHEMA 70 0.0003
597 SYNCOPE 34 0.0003
598 LYMPHADENOPATHY 12 0.0003
599 COVID-19 PNEUMONIA 4 0.0003
600 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
601 FACIAL PAIN 3 0.0003
602 PULMONARY HYPERTENSION 7 0.0003
603 THERAPY INTERRUPTED 24 0.0003
604 ACCIDENT 4 0.0003
605 JAUNDICE 9 0.0003
606 FLUID RETENTION 17 0.0003
607 HYPOAESTHESIA ORAL 5 0.0003
608 PRODUCT QUALITY ISSUE 45 0.0003
609 LETHARGY 19 0.0003
610 EATING DISORDER 7 0.0003
611 EXOSTOSIS 3 0.0003
612 MALAISE 144 0.0003
613 HIP ARTHROPLASTY 5 0.0003
614 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
615 POOR QUALITY SLEEP 7 0.0003
616 SKIN CANCER 7 0.0003
617 NERVE COMPRESSION 3 0.0003
618 PROCEDURAL PAIN 9 0.0003
619 BACK PAIN 75 0.0003
620 SWELLING FACE 21 0.0003
621 LUNG INFECTION 5 0.0003
622 CARDIAC DISORDER 30 0.0003
623 FLANK PAIN 3 0.0003
624 LOSS OF CONSCIOUSNESS 41 0.0003
625 LEUKOPENIA 16 0.0003
626 DIZZINESS 159 0.0003
627 DYSPHAGIA 30 0.0003
628 TACHYCARDIA 28 0.0003
629 EYE INFLAMMATION 3 0.0003
630 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
631 TREMOR 52 0.0003
632 INJECTION SITE PAIN 95 0.0003
633 PRURITUS 119 0.0003
634 HIATUS HERNIA 4 0.0003
635 EXPOSURE VIA SKIN CONTACT 8 0.0003
636 PRODUCT STORAGE ERROR 27 0.0003
637 VITAMIN D DEFICIENCY 3 0.0003
638 HAEMORRHOIDS 6 0.0003
639 ORAL HERPES 6 0.0003
640 LUNG DISORDER 15 0.0003
641 KNEE OPERATION 3 0.0003
642 ASPERGILLUS INFECTION 2 0.0003
643 UNEVALUABLE EVENT 23 0.0003
644 URINARY INCONTINENCE 9 0.0003
645 PANCREATITIS 16 0.0003
646 RENAL DISORDER 14 0.0003
647 OVARIAN CYST 3 0.0003
648 DEVICE DISLOCATION 13 0.0003
649 MALIGNANT MELANOMA 4 0.0003
650 QUALITY OF LIFE DECREASED 4 0.0003
651 INCORRECT DOSE ADMINISTERED 68 0.0003
652 FEEDING DISORDER 6 0.0003
653 TASTE DISORDER 6 0.0003
654 EYE SWELLING 11 0.0003
655 OEDEMA PERIPHERAL 36 0.0003
656 HEMIPARESIS 5 0.0003
657 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
658 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
659 DRUG TOXICITY 4 0.0003
660 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
661 EUPHORIC MOOD 3 0.0003
662 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
663 COLITIS ULCERATIVE 13 0.0003
664 MUSCULAR WEAKNESS 33 0.0003
665 PRESYNCOPE 7 0.0003
666 HYPOAESTHESIA 43 0.0003
667 APHONIA 4 0.0003
668 WOUND 8 0.0003
669 ABDOMINAL DISCOMFORT 48 0.0003
670 RASH MACULAR 10 0.0003
671 DEVICE USE ISSUE 5 0.0003
672 CARPAL TUNNEL SYNDROME 4 0.0003
673 INJECTION SITE URTICARIA 7 0.0003
674 INJECTION SITE DISCOMFORT 3 0.0003
675 NEUROPATHY PERIPHERAL 27 0.0003
676 INCONTINENCE 3 0.0003
677 JOINT DISLOCATION 3 0.0003
678 FULL BLOOD COUNT ABNORMAL 3 0.0003
679 BRADYCARDIA 15 0.0003
680 HAEMOGLOBIN DECREASED 29 0.0003
681 SINUS TACHYCARDIA 4 0.0003
682 GALLBLADDER DISORDER 5 0.0003
683 ARTHRITIS 22 0.0003
684 ARTHRALGIA 116 0.0003
685 DECREASED ACTIVITY 3 0.0003
686 ANXIETY 79 0.0003
687 DEHYDRATION 37 0.0003
688 PARAESTHESIA ORAL 4 0.0003
689 INJECTION SITE REACTION 19 0.0003
690 RESTLESS LEGS SYNDROME 5 0.0003
691 ASTHMA 31 0.0003
692 RESPIRATORY FAILURE 20 0.0003
693 DIARRHOEA 177 0.0003
694 HEPATITIS 7 0.0003
695 ASCITES 8 0.0003
696 ANGIOEDEMA 12 0.0003
697 FOOT DEFORMITY 3 0.0003
698 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
699 TOOTH DISORDER 6 0.0003
700 HAEMORRHAGE INTRACRANIAL 4 0.0003
701 ATRIAL FIBRILLATION 26 0.0003
702 BLOOD CALCIUM DECREASED 3 0.0003
703 GASTRITIS 7 0.0003
704 INTESTINAL OBSTRUCTION 10 0.0003
705 MITRAL VALVE INCOMPETENCE 3 0.0003
706 SCAB 3 0.0003
707 PROTEINURIA 5 0.0003
708 AORTIC ANEURYSM 2 0.0003
709 VISION BLURRED 36 0.0003
710 BLOOD CREATININE INCREASED 17 0.0003
711 MUSCLE TWITCHING 6 0.0003
712 ANKLE FRACTURE 4 0.0003
713 CAESAREAN SECTION 3 0.0003
714 ABDOMINAL PAIN UPPER 53 0.0003
715 NERVOUS SYSTEM DISORDER 8 0.0003
716 HEART RATE DECREASED 9 0.0003
717 SKIN LESION 7 0.0003
718 SLEEP DISORDER 18 0.0003
719 CYANOSIS 4 0.0003
720 INJECTION SITE PRURITUS 17 0.0003
721 RESPIRATORY DISTRESS 7 0.0003
722 ASTHENIA 95 0.0003
723 NECK PAIN 14 0.0003
724 FEELING ABNORMAL 60 0.0003
725 CARDIAC FAILURE CONGESTIVE 20 0.0002
726 INJECTION SITE SWELLING 19 0.0002
727 CRYING 9 0.0002
728 MYALGIA 42 0.0002
729 HYPERGLYCAEMIA 9 0.0002
730 FLATULENCE 14 0.0002
731 BONE MARROW FAILURE 5 0.0002
732 BACK DISORDER 4 0.0002
733 LIVER INJURY 6 0.0002
734 DYSPEPSIA 24 0.0002
735 GENERALISED OEDEMA 3 0.0002
736 PHOTOSENSITIVITY REACTION 4 0.0002
737 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
738 NEEDLE ISSUE 7 0.0002
739 RASH PRURITIC 13 0.0002
740 POLLAKIURIA 10 0.0002
741 GAIT INABILITY 8 0.0002
742 SKIN DISCOLOURATION 11 0.0002
743 RASH 104 0.0002
744 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
745 TREATMENT NONCOMPLIANCE 13 0.0002
746 COLITIS 9 0.0002
747 CARDIOVASCULAR DISORDER 6 0.0002
748 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
749 ADVERSE DRUG REACTION 21 0.0002
750 INJECTION SITE ERYTHEMA 29 0.0002
751 THERAPY CESSATION 12 0.0002
752 LIVER FUNCTION TEST INCREASED 5 0.0002
753 RECTAL HAEMORRHAGE 10 0.0002
754 MUSCULOSKELETAL DISCOMFORT 4 0.0002
755 APHASIA 7 0.0002
756 PRURITUS GENERALISED 5 0.0002
757 PLATELET COUNT INCREASED 3 0.0002
758 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
759 MUSCULOSKELETAL PAIN 12 0.0002
760 INJECTION SITE RASH 7 0.0002
761 SKIN EXFOLIATION 19 0.0002
762 DECREASED APPETITE 52 0.0002
763 RASH PAPULAR 5 0.0002
764 TOOTHACHE 4 0.0002
765 DRY EYE 11 0.0002
766 HAEMORRHAGE 23 0.0002
767 END STAGE RENAL DISEASE 4 0.0002
768 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
769 RESPIRATORY ARREST 6 0.0002
770 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
771 PARAESTHESIA 34 0.0002
772 ARTHROPATHY 12 0.0002
773 HYPOMAGNESAEMIA 3 0.0002
774 HUNGER 3 0.0002
775 HYPOTENSION 43 0.0002
776 BLOOD TEST ABNORMAL 3 0.0002
777 SKIN REACTION 3 0.0002
778 EYE DISORDER 7 0.0002
779 PHOTOPHOBIA 4 0.0002
780 CONSTIPATION 46 0.0002
781 GASTRIC ULCER 4 0.0002
782 LIP SWELLING 7 0.0002
783 SPEECH DISORDER 11 0.0002
784 SOMNOLENCE 42 0.0002
785 BALANCE DISORDER 18 0.0002
786 LOWER LIMB FRACTURE 4 0.0002
787 HYPOKINESIA 3 0.0002
788 LIVER FUNCTION TEST ABNORMAL 6 0.0002
789 ADVERSE EVENT 19 0.0002
790 GASTROENTERITIS 3 0.0002
791 DYSSTASIA 6 0.0002
792 AUTOIMMUNE DISORDER 2 0.0002
793 DYSPHONIA 12 0.0002
794 CHOKING 4 0.0002
795 GASTRIC DISORDER 7 0.0002
796 SKIN HAEMORRHAGE 3 0.0002
797 DRY SKIN 27 0.0002
798 HYPERHIDROSIS 26 0.0002
799 PULMONARY MASS 3 0.0002
800 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
801 IRRITABILITY 12 0.0002
802 INJURY 14 0.0002
803 PROSTATE CANCER 16 0.0002
804 EMOTIONAL DISTRESS 24 0.0002
805 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
806 ECONOMIC PROBLEM 3 0.0002
807 ILL-DEFINED DISORDER 12 0.0002
808 EXTRA DOSE ADMINISTERED 8 0.0002
809 SKIN IRRITATION 9 0.0002
810 BLINDNESS 8 0.0002
811 RIB FRACTURE 4 0.0002
812 INJECTION SITE WARMTH 4 0.0002
813 OFF LABEL USE 170 0.0002
814 MUSCULOSKELETAL STIFFNESS 17 0.0002
815 MUSCULOSKELETAL CHEST PAIN 3 0.0002
816 HAEMATOMA 5 0.0002
817 DEAFNESS 5 0.0002
818 ARRHYTHMIA 9 0.0002
819 MOUTH ULCERATION 4 0.0002
820 DEPRESSED MOOD 10 0.0002
821 OBESITY 3 0.0002
822 ABSCESS 3 0.0002
823 HYPOTHYROIDISM 6 0.0002
824 SENSORY DISTURBANCE 3 0.0002
825 ANAEMIA 35 0.0002
826 MOBILITY DECREASED 13 0.0002
827 VISUAL ACUITY REDUCED 6 0.0002
828 BLOOD GLUCOSE INCREASED 34 0.0002
829 LIVER DISORDER 8 0.0002
830 RASH MACULO-PAPULAR 4 0.0002
831 NEOPLASM MALIGNANT 12 0.0002
832 PANCYTOPENIA 10 0.0002
833 CHROMATURIA 4 0.0002
834 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
835 DISORIENTATION 7 0.0002
836 DRUG INTOLERANCE 17 0.0002
837 MEMORY IMPAIRMENT 24 0.0002
838 INFLAMMATION 9 0.0002
839 PARANOIA 3 0.0002
840 SHOCK 4 0.0002
841 LOCAL SWELLING 3 0.0002
842 SYRINGE ISSUE 3 0.0002
843 DERMATITIS ATOPIC 9 0.0002
844 INFLUENZA LIKE ILLNESS 14 0.0002
845 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
846 LABORATORY TEST ABNORMAL 5 0.0002
847 DRUG ERUPTION 3 0.0002
848 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
849 PRODUCT PRESCRIBING ERROR 4 0.0002
850 CONFUSIONAL STATE 27 0.0002
851 HEPATIC FAILURE 5 0.0002
852 LEUKOCYTOSIS 3 0.0002
853 MENTAL IMPAIRMENT 4 0.0002
854 ADRENAL INSUFFICIENCY 2 0.0002
855 INJECTION SITE MASS 6 0.0002
856 CARDIAC FAILURE 13 0.0002
857 ABNORMAL WEIGHT GAIN 2 0.0002
858 DEVICE LEAKAGE 7 0.0002
859 VAGINAL HAEMORRHAGE 7 0.0002
860 HEPATIC STEATOSIS 3 0.0002
861 THROMBOCYTOPENIA 18 0.0002
862 SEPTIC SHOCK 7 0.0002
863 APPLICATION SITE IRRITATION 2 0.0002
864 BLISTER 9 0.0002
865 HALLUCINATION 12 0.0002
866 BLOOD URINE PRESENT 3 0.0002
867 PULMONARY EMBOLISM 15 0.0002
868 GAIT DISTURBANCE 30 0.0002
869 HYPOPHAGIA 4 0.0002
870 METABOLIC ACIDOSIS 5 0.0002
871 PULMONARY OEDEMA 7 0.0002
872 CHOLESTASIS 3 0.0002
873 GLAUCOMA 3 0.0002
874 DYSTONIA 3 0.0002
875 BONE PAIN 9 0.0002
876 SKIN BURNING SENSATION 11 0.0002
877 JOINT STIFFNESS 4 0.0002
878 IMPAIRED HEALING 5 0.0002
879 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
880 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
881 SKIN DISORDER 5 0.0001
882 DEPRESSION 34 0.0001
883 TYPE 2 DIABETES MELLITUS 5 0.0001
884 THERAPEUTIC RESPONSE DECREASED 9 0.0001
885 ANGER 5 0.0001
886 INJURY ASSOCIATED WITH DEVICE 3 0.0001
887 VISUAL IMPAIRMENT 18 0.0001
888 MENTAL STATUS CHANGES 4 0.0001
889 DEVICE USE ERROR 5 0.0001
890 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
891 IRRITABLE BOWEL SYNDROME 3 0.0001
892 RED BLOOD CELL COUNT DECREASED 4 0.0001
893 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
894 ANOSMIA 2 0.0001
895 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
896 PANIC ATTACK 5 0.0001
897 CEREBROVASCULAR ACCIDENT 23 0.0001
898 ACUTE MYOCARDIAL INFARCTION 4 0.0001
899 DRY MOUTH 11 0.0001
900 TRANSAMINASES INCREASED 3 0.0001
901 DYSGEUSIA 10 0.0001
902 ORAL PAIN 3 0.0001
903 ECZEMA 7 0.0001
904 NEUTROPENIA 18 0.0001
905 INSOMNIA 35 0.0001
906 DIABETES MELLITUS 10 0.0001
907 EPILEPSY 4 0.0001
908 DRUG INEFFECTIVE 172 0.0001
909 DRUG ADMINISTRATION ERROR 4 0.0001
910 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
911 DISTURBANCE IN ATTENTION 7 0.0001
912 COGNITIVE DISORDER 6 0.0001
913 DEVICE MALFUNCTION 9 0.0001
914 HIP FRACTURE 4 0.0001
915 NIGHT SWEATS 4 0.0001
916 LACTIC ACIDOSIS 4 0.0001
917 FIBROMYALGIA 3 0.0001
918 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
919 DEEP VEIN THROMBOSIS 8 0.0001
920 AMNESIA 8 0.0001
921 OSTEOPOROSIS 5 0.0001
922 CARDIAC ARREST 10 0.0001
923 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
924 CARDIO-RESPIRATORY ARREST 5 0.0001
925 CATARACT 7 0.0001
926 DEATH 100 0.0001
927 SKIN ULCER 3 0.0001
928 SEDATION 3 0.0001
929 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
930 HYPERKALAEMIA 4 0.0001
931 INJECTION SITE BRUISING 9 0.0001
932 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
933 ALOPECIA 22 0.0001
934 FEAR 3 0.0001
935 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
936 ACUTE KIDNEY INJURY 17 0.0001
937 ACCIDENTAL OVERDOSE 4 0.0001
938 AGITATION 8 0.0001
939 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
940 HOT FLUSH 8 0.0001
941 CONVULSION 6 0.0001
942 ANGINA PECTORIS 3 0.0001
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
944 HYPOGLYCAEMIA 5 0.0001
945 PLASMA CELL MYELOMA 4 0.0001
946 AGGRESSION 5 0.0001
947 PREMATURE BABY 3 0.0001
948 STOMATITIS 6 0.0001
949 DEVICE BREAKAGE 4 0.0001
950 SUICIDAL IDEATION 9 0.0001
951 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
952 FEMUR FRACTURE 3 0.0001
953 NERVOUSNESS 5 0.0001
954 RENAL IMPAIRMENT 8 0.0001
955 DRUG INTERACTION 15 0.0001
956 DRUG EFFECT DECREASED 5 0.0001
957 INTENTIONAL PRODUCT MISUSE 8 0.0001
958 URINARY RETENTION 3 0.0001
959 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
960 RHEUMATOID ARTHRITIS 10 0.0001
961 INJECTION SITE HAEMORRHAGE 7 0.0001
962 HYPOKALAEMIA 4 0.0001
963 DISEASE PROGRESSION 10 0.0001
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
965 MULTIPLE SCLEROSIS 4 0.0001
966 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
967 RENAL FAILURE 11 0.0001
968 PLEURAL EFFUSION 5 0.0001
969 ABASIA 2 0.0001
970 AGEUSIA 2 0.0001
971 ABDOMINAL PAIN LOWER 2 0.0001
972 PSORIASIS 10 0.0001
973 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
974 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
975 WITHDRAWAL SYNDROME 3 0.0001
976 RENAL FAILURE ACUTE 3 0.0001
977 UNDERDOSE 5 0.0001
978 DISEASE RECURRENCE 3 0.0001
979 MYOCARDIAL INFARCTION 11 0.0001
980 COMA 3 0.0001
981 DRUG DOSE OMISSION 9 0.0001
982 ACNE 4 0.0001
983 CHRONIC KIDNEY DISEASE 4 0.0001
984 OVERDOSE 11 0.0001
985 ABNORMAL BEHAVIOUR 2 0.0001
986 ABORTION SPONTANEOUS 2 0.0000
987 PRODUCT DOSE OMISSION 3 0.0000
988 BREAST CANCER 4 0.0000
989 TOXICITY TO VARIOUS AGENTS 4 0.0000
990 DRUG DEPENDENCE 3 0.0000